Representative before the EPO

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
1283.4
Headquarter in Copenhagen and 16 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Company dna novitas patent ab
no operation time available
1 office
active in Legal Services

We have observed 12 EP applications Jarkko Kortesmaa has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12756469

METHOD FOR INCREASING ETEC CS6 ANTIGEN PRESENTATION ON CELL SURFACE AND PRODUCTS OBTAINABLE THEREOF

IPC classification:
A61K 39/02
Agent:
Jarkko Kortesmaa, Zacco
Agent:
Jarkko Kortesmaa, Novitas Patent AB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12737010

DROUGHT RESISTANT PLANTS AND METHODS FOR MAKING THE SAME USING TRANSCRIPTIONAL REGULATORS

IPC classification:
C12N 15/82
Agent:
Jarkko Kortesmaa, Zacco
Status:
EXAMINATION IN PROGRESS
EP12738829

ZSCAN4 AS A MARKER FOR PANCREATIC STEM CELLS AND PROGENITOR CELLS AND USE THEREOF

IPC classification:
G01N 33/50, C12N 5/095
Agent:
Jarkko Kortesmaa, Zacco
Status:
The patent has been granted
EP12786407

DETECTION OF SAXITOXIN-PRODUCING DINOFLAGELLATES

IPC classification:
C12Q 1/68, C12Q 1/25, C12N 15/52, C12N 9/00
Applicant:
University of Oslo (Universitetet i Oslo)
Agent:
Jarkko Kortesmaa, Zacco
Status:
EXAMINATION IN PROGRESS
EP12711091

MUTANT CELLS FOR PROTEIN SECRETION AND LIGNOCELLULOSE DEGRADATION

IPC classification:
C12P 21/00, C12N 9/24
Applicant:
University of California
Agent:
Jarkko Kortesmaa, Zacco
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11827555

METHODS OF TREATING CANCER COMPRISING TARGETING NQO1

IPC classification:
A61P 35/00, A61K 31/22, C12Q 1/68
Agent:
Jarkko Kortesmaa, Zacco
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
The patent has been granted
EP12760251

COMPOSITIONS AND METHODS FOR ENHANCING THE PLURIPOTENCY OF STEM CELLS

IPC classification:
C12P 21/02, C07K 14/705, C07K 14/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jarkko Kortesmaa, Zacco
Status:
GRANT OF PATENT INTENDED
EP13189112

Inhibitors of focal adhesion kinase

IPC classification:
A61K 31/47, C07D 491/113, C07D 417/14, C07D 417/12, C07D 413/12, C07D 405/12, C07D 401/14, C07D 401/12, C07D 213/74, C07D 213/72, A61P 35/00
Agent:
Jarkko Kortesmaa, Zacco
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12785169

USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS

IPC classification:
C12N 15/85, C12N 15/63, C12N 15/00, C12N 5/10, C12N 5/074, C12N 5/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jarkko Kortesmaa, Zacco
Status:
The patent has been granted
EP11808093

THERMOSTABLE C. BESCII ENZYMES

IPC classification:
C07K 14/195, C12P 1/04
Agent:
Jarkko Kortesmaa, Zacco
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12704212

ENHANCED CELLODEXTRIN METABOLISM

IPC classification:
C12P 7/08
Applicant:
University of California
Agent:
Jarkko Kortesmaa, Zacco
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11808394

NOVEL BIOMARKER AND USES THEREOF IN DIAGNOSIS, TREATMENT OF AUTISM

IPC classification:
G01N 33/68, A61K 31/245, A61K 31/17, A61K 38/57, A61K 38/55, A61K 38/04, C07K 14/47
Agent:
Jarkko Kortesmaa, Zacco
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature